Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erminio Bonizzoni

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
BMC Cancer|January 1, 2020
Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidenceLuigi Celio, Erminio Bonizzoni, Emma Zattarin, et al.
Epilepsy Research|December 15, 2015
Antiepileptic drug use and epileptic seizures in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first surveyCarlo Andrea Galimberti, Elena Tartara, Sabrina Dispenza, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 2012
Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trialsLuigi Celio, Erminio Bonizzoni, Emilio Bajetta, et al.
Future Oncology (London, England)|June 21, 2014
Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapyAurora Mirabile, Luigi Celio, Michele Magni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 18, 2014
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimenLuigi Rigacci, Benedetta Puccini, Sofia Kovalchuk, et al.
Future Oncology (London, England)|April 21, 2021
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysisRudolph M Navari, Gary Binder, Erminio Bonizzoni, et al.
Epilepsia|July 16, 2013
Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registryDina Battino, Torbjörn Tomson, Erminio Bonizzoni, et al.
Diabetes Care|June 6, 2013
Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trialEmanuele Bosi, Marina Scavini, Antonio Ceriello, et al.
British Journal of Clinical Pharmacology|January 24, 2015
Pharmacokinetic study between a bilayer matrix fentalyl patch and a monolayer matrix fentanyl patch: single dose administration in healthy volunteersErnesto Zecca, Andrea Manzoni, Fabio Centurioni, et al.
Transplantation|September 17, 2004
Is cyclosporine in renal-transplant recipients more effective when given twice a day than in a single daily dose?Antonio Tarantino, Patrizia Passerini, Mariarosaria Campise, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
BMC Cancer|January 1, 2020
Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidenceLuigi Celio, Erminio Bonizzoni, Emma Zattarin, et al.
Epilepsy Research|December 15, 2015
Antiepileptic drug use and epileptic seizures in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first surveyCarlo Andrea Galimberti, Elena Tartara, Sabrina Dispenza, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 2012
Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trialsLuigi Celio, Erminio Bonizzoni, Emilio Bajetta, et al.
Future Oncology (London, England)|June 21, 2014
Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapyAurora Mirabile, Luigi Celio, Michele Magni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 18, 2014
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimenLuigi Rigacci, Benedetta Puccini, Sofia Kovalchuk, et al.
Future Oncology (London, England)|April 21, 2021
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysisRudolph M Navari, Gary Binder, Erminio Bonizzoni, et al.
Epilepsia|July 16, 2013
Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registryDina Battino, Torbjörn Tomson, Erminio Bonizzoni, et al.
Diabetes Care|June 6, 2013
Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trialEmanuele Bosi, Marina Scavini, Antonio Ceriello, et al.
British Journal of Clinical Pharmacology|January 24, 2015
Pharmacokinetic study between a bilayer matrix fentalyl patch and a monolayer matrix fentanyl patch: single dose administration in healthy volunteersErnesto Zecca, Andrea Manzoni, Fabio Centurioni, et al.
Transplantation|September 17, 2004
Is cyclosporine in renal-transplant recipients more effective when given twice a day than in a single daily dose?Antonio Tarantino, Patrizia Passerini, Mariarosaria Campise, et al.
Pageof 9